par Larsimont, Denis
;Durbecq, Virginie
;Awada, Ahmad
;Di Leo, Angelo 
Référence Bulletin du cancer, 95, 3, page (344-351)
Publication Publié, 2008-03




Référence Bulletin du cancer, 95, 3, page (344-351)
Publication Publié, 2008-03
Article révisé par les pairs
Titre: |
|
Auteur: | Larsimont, Denis; Durbecq, Virginie; Awada, Ahmad; Di Leo, Angelo |
Informations sur la publication: | Bulletin du cancer, 95, 3, page (344-351) |
Statut de publication: | Publié, 2008-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Breast cancer |
HER2 | |
Topoisomerase IIα | |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antigens, Neoplasm -- analysis | |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- chemistry | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- genetics | |
Carcinoma, Ductal, Breast -- chemistry | |
Carcinoma, Ductal, Breast -- drug therapy | |
Chromosome Aberrations | |
Chromosomes, Human, Pair 17 -- genetics | |
DNA Topoisomerases, Type II, Eukaryotic -- analysis | |
DNA-Binding Proteins -- analysis | |
Female | |
Gene Amplification | |
Genes, erbB-2 | |
Guidelines as Topic | |
Humans | |
Immunohistochemistry | |
In Situ Hybridization, Fluorescence | |
Predictive Value of Tests | |
Receptor, erbB-2 -- analysis | |
Receptor, erbB-2 -- chemistry | |
Tumor Markers, Biological -- analysis | |
Note générale: | English Abstract |
Journal Article | |
Review | |
Langue: | Français |
Identificateurs: | urn:issn:0007-4551 |
info:doi/10.1684/bdc.2008.0596 | |
info:pii/bdc.2008.0596 | |
info:scp/42149126122 | |
info:pmid/18390415 |